The Global Uveitis Treatment Market Is Expected To Be Worth US$ 648.4 Million In 2020, Rising To US$ 1,036.0 Million By The End Of 2027

-
Uveitis Treatment Market
Uveitis Treatment Market

Uveitis is an inflammation of the uvea, the middle layer of the eye that includes the iris, ciliary body, and choroid. The condition is classified as anterior uveitis, intermediate uveitis, posterior uveitis, or diffuse uveitis based on where the inflammation occurs in the uvea.

The high prevalence of uveitis is expected to drive global Uveitis Treatment Market growth over the forecast period. According to the study 'Epidemiology of uveitis in urban Australia,' published in the journal Clinical and Experimental Ophthalmology in April 2019, the incidence of uveitis was 21.54 per 100 000 person?years. The condition had a period prevalence of 36.27 per 100 000 people. Furthermore, the high prevalence of autoimmune disorders is expected to contribute to market growth. According to a National MS Society study published in the journal Neurology in February 2019, nearly 1 million adults in the United States had multiple sclerosis in 2017.

Asia Pacific has a high prevalence of anterior Uveitis Treatment Market. According to the study 'Epidemiology of uveitis in urban Australia,' published in the journal Clinical and Experimental Ophthalmology in April 2019, the distribution of prevalent uveitis cases was anterior (75%), intermediate (6%), posterior (15%), and panuveitis (4%). Several clinical trials have been halted due to the discovery of Covid-19. For example, Galapagos, based in Belgium, announced in March 2020 that it is suspending enrollment in some clinical trials, including filgotinib Phase II and Phase III trials in Crohn's disease, psoriatic arthritis, and uveitis.

Limited studies on the efficacy comparison of treating agents are expected to Uveitis Treatment Market growth. Because there have been very few studies on the efficacy of the agents used to treat uveitis, there have been very few first-line drugs introduced for treatment. Patients with various forms of uveitis exhibit varying behaviour, with varying diagnoses and treatment success. Furthermore, the difficult manufacturing process is expected to limit market growth. Eye care products require a unique manufacturing process in order to be properly aligned with GMP regulations for sterile products. Because the formulations are susceptible to pathogens found in the environment, they are created in a highly protected environment.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Global Report on LED Driver Market for the Forecast Period 2023-2030

-
Image
LED Driver Market The LED Driver Market has been growing rapidly over the past few years, driven by the increasing demand for energy-efficient lighting solutions across residential, commercial, and industrial sectors. LED (light-emitting diode) lighting technology has several advantages over traditional lighting solutions such as incandescent and fluorescent lights, including longer lifespan, lower energy consumption, and lower maintenance costs. However, to power and control LED lights, an LED driver is required. The LED Driver Market was valued at USD 7.7 billion in 2020 and is expected to reach USD 10.5 billion by 2025, at a CAGR of 6.4% during the forecast period. LED drivers are electronic devices that regulate the power supply to LED lights. They convert AC voltage from a power source to DC voltage suitable for LEDs, and also provide the necessary current and voltage regulation to ensure proper functioning of the LED lights. LED drivers can be either constant current or constant
Read more